These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure. Stanek B; Frey B; Hülsmann M; Koller-Strametz J; Hartter E; Schuller M; Ogris E; Maurer G; Pacher R Transplant Proc; 1997; 29(1-2):595-6. PubMed ID: 9123146 [No Abstract] [Full Text] [Related]
25. Rapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis. Kinoshita O; Yoshimi H; Nagata S; Ishikura F; Kimura K; Yamabe T; Takagaki K; Miyatake K; Omae T Br Heart J; 1993 Apr; 69(4):322-6. PubMed ID: 8489864 [TBL] [Abstract][Full Text] [Related]
26. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330 [TBL] [Abstract][Full Text] [Related]
27. Plasma endothelin following cardiac arrest: differences between survivors and non-survivors. Haynes WG; Hamer DW; Robertson CE; Webb DJ Resuscitation; 1994 Mar; 27(2):117-22. PubMed ID: 8029532 [TBL] [Abstract][Full Text] [Related]
28. Plasma endothelin-1 in acute myocardial infarction with heart failure. Tomoda H Am Heart J; 1993 Mar; 125(3):667-72. PubMed ID: 8438694 [TBL] [Abstract][Full Text] [Related]
29. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238 [TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction. Gottlieb SS; Harris K; Todd J; Estis J; Christenson RH; Torres V; Whittaker K; Rebuck H; Wawrzyniak A; Krantz DS Clin Biochem; 2015 Mar; 48(4-5):292-6. PubMed ID: 25541019 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients. Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407 [TBL] [Abstract][Full Text] [Related]
37. The potential role of endothelin as a vasoconstrictor substance in congestive heart failure. Cody RJ Eur Heart J; 1992 Nov; 13(11):1573-8. PubMed ID: 1464346 [TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Hartmann F; Packer M; Coats AJ; Fowler MB; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Anker SD; Amann-Zalan I; Hoersch S; Katus HA Circulation; 2004 Sep; 110(13):1780-6. PubMed ID: 15381643 [TBL] [Abstract][Full Text] [Related]
39. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Berger R; Huelsman M; Strecker K; Bojic A; Moser P; Stanek B; Pacher R Circulation; 2002 May; 105(20):2392-7. PubMed ID: 12021226 [TBL] [Abstract][Full Text] [Related]
40. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]